Three million child deaths associated with drug resistance

More than three million children worldwide died in 2022 as a result of antibiotics infections, according to a study of two leading children’s health experts.

It was recognized that children in Africa and Southeast Asia are at the most risk.

Antimicrobial resistance – known as AMR – develops when germs that cause infections develop in such a way that antibiotic drugs are no longer working.

He was recognized as one of the largest public health threats facing the world.

A new study now shows that AMR is taking children.

Using data from various sources, including the World Health Organization (WHO) and the World Bank, the report authors estimate that in 2022, in 2022, it was associated with infections resistant to drugs.

Experts note that this new study emphasizes more than a ten -time increase in AMR infections in children in just three years.

The number may deteriorate from the impact of the pandemic.

Antibiotics are used to treat or prevent a huge range of bacterial infections – all: from skin infections to pneumonia.

They are also sometimes given as a precaution to prevent, not treatment, infections – for example, if someone has surgery or receiving chemotherapy for cancer.

Antibiotics do not affect viral infections – diseases such as colds, influenza or pre -factory.

But some bacteria have now developed resistance to some drugs from their excessive use and inadequate use, while the production of new antibiotics – a long and expensive process – slowed down.

Leading authors of the report, Dr. Yanhun Jessico Her of the Merdak Children’s Scientific and Research Institute and Professor Girvel Harvel on the Clinton’s health initiative, indicate a significant increase in the use of antibiotics that should be restrained only for the most serious infections.

Between 2019 and 2021, the use of “antibiotics”, high -risk drugs, increased by 160% in Southeast Asia and 126% in Africa.

During the same period, “reserve antibiotics” – treatment in the latest profitability in severe, resistant to many infections – increased by 45% in Southeast Asia and 125% in Africa.

The authors warn that if the bacteria develops resistance to these antibiotics, there will be little, if any, alternatives for the treatment of many infections.

Professor Harvel presents conclusions at the Congress of the European Society of Clinical Microbiology and Infectious Diseases in Vienna at the end of this month.

“AMR is a global problem. It affects everyone. We did this job really to focus on a disproportionate way when AMR touches children,” he said on the eve of the event.

“We estimate the three million deaths of children worldwide associated with antimicrobial resistance.”

WHO describes Amr as one of the most serious global health threats We are confronted, but, speaking from Vienna, Professor Harvel warns that there was no answer.

“This is a multifaceted problem that spreads to all aspects of medicine and indeed, human life,” he said.

“Antibiotics are ubiquitous around us, they get into food and the environment, and therefore it is not easy to come up with a single solution.”

The best way to avoid sustainable infection is to avoid infection generally, which means a higher level of immunization, water and hygiene, it adds.

“There will be more use of antibiotics because there are more people who need them, but we need to make sure they are used properly and the right medicines are used.”

D -R -Linds Edwards, Senior Microbiology Lecturer in King London, said a new study “means a significant and disturbing increase compared to previous data.”

“These conclusions should be called for wakefulness for global health leaders. Without decisive AMR action, it can undermine decades of children’s health progress, especially in the most vulnerable regions of the world.”